EUVIMEDEUVIMED entdecken
Crossref

74151 Characterizing immune checkpoint inhibitor-associated vitiligo: a single-institution cohort

Katie Lu, Kristen Enriquez, Allison Dobry

Journal of the American Academy of Dermatology · 2026-07 · 95 (1) · AB98

DOI: 10.1016/j.jaad.2026.04.402 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Academy of Dermatology, 2026-07. Verfasst von Katie Lu und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Lu, K., Enriquez, K., & Dobry, A. (2026). 74151 Characterizing immune checkpoint inhibitor-associated vitiligo: a single-institution cohort. Journal of the American Academy of Dermatology, 95(1), AB98. https://doi.org/10.1016/j.jaad.2026.04.402

Vancouver

Lu K, Enriquez K, Dobry A. 74151 Characterizing immune checkpoint inhibitor-associated vitiligo: a single-institution cohort. Journal of the American Academy of Dermatology. 2026;95(1):AB98. doi:10.1016/j.jaad.2026.04.402

BibTeX
@article{Lu2026,
  author = {Lu, Katie and Enriquez, Kristen and Dobry, Allison},
  title = {74151 Characterizing immune checkpoint inhibitor-associated vitiligo: a single-institution cohort},
  journal = {Journal of the American Academy of Dermatology},
  year = {2026},
  volume = {95},
  number = {1},
  pages = {AB98},
  doi = {10.1016/j.jaad.2026.04.402}
}
Kostenlos starten →